Fatigue News and Research

RSS

Lifting lighter weights many times can be effective alternative way to gain muscle strength

New research from McMaster University is challenging traditional workout wisdom, suggesting that lifting lighter weights many times is as efficient as lifting heavy weights for fewer repetitions.

12 Jul 2016

Study identifies new blood markers to accurately diagnose Gulf War Illness

Based on a study of 85 Gulf War veterans, Veterans Affairs researchers in Minneapolis have developed a tentative panel of blood markers they say can verify a diagnosis of Gulf War Illness with 90 percent accuracy.

11 Jul 2016

Moderate to vigorous physical activity linked to improved memory in breast cancer survivors

Moderate-to-vigorous physical activity is related to improved subjective memory in breast cancer survivors, who often complain about memory problems, reports a new Northwestern Medicine study.

8 Jul 2016

Relaxing acupressure improves fatigue levels in breast cancer survivors

Acupressure helped reduce persistent fatigue in women who had been treated for breast cancer, a new study finds.

7 Jul 2016

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year.

6 Jul 2016

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.

6 Jul 2016

FDA approves Absorb GT1 BVS to treat coronary artery disease

The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease.

5 Jul 2016

First-line nivolumab promising in advanced NSCLC

Phase I results published in the Journal of Clinical Oncology suggest that nivolumab, either given alone or alongside platinum-based doublet chemotherapy, could have a role in the first-line treatment of advanced non-small-cell lung cancer.

5 Jul 2016

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients

A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and tolerability in patients with advanced colorectal cancer, according to phase III data presented at the European Society for Medical Oncology's 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.

4 Jul 2016

Wolbachia bacterium can prevent mosquitoes from transmitting Zika virus

Researchers at the University of Wisconsin-Madison have confirmed that a benign bacterium called Wolbachia pipientis can completely block transmission of Zika virus in Aedes aegypti, the mosquito species responsible for passing the virus to humans.

1 Jul 2016

Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.

30 Jun 2016

Study highlights continuing problem of MSI in Gulf War veterans

Veterans of the Gulf War are more than twice as likely to have medically unexplained symptoms known as "multisymptom illness" (MSI), compared to Iraq/Afghanistan War veterans, according to an updated research review in the July Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

30 Jun 2016

Epclusa drug receives FDA approval for treating adult patients with chronic HCV

The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease).

28 Jun 2016

Why does appetite loss occur during illness? An interview with Prof. Conti and Prof. Francesconi

Appetite, as a word, come from the Latin appetitus, meaning "desire for.” Therefore, appetite can be defined as a pleasurable sensation or the desire to eat. This sensation is coordinated by several brain areas associated with reward processing such amygdala, hippocampus, ventral pallidum, nucleus accumbens and striatum, and others.

28 Jun 2016

The scent dogs smell on diabetics’ breath could offer key to new tests

An increase in the level of the chemical isoprene may be the warning sign some dogs can detect in the breath of patients with type 1 diabetes who are reaching risky low levels of blood sugar, according to research by the University of Cambridge.

28 Jun 2016

Scientists detect biological markers of chronic fatigue syndrome in gut bacteria

Physicians have been mystified by chronic fatigue syndrome, a condition where normal exertion leads to debilitating fatigue that isn't alleviated by rest. There are no known triggers, and diagnosis requires lengthy tests administered by an expert.

28 Jun 2016

Stony Brook researcher receives grant to evaluate daily activity levels, heart rate patterns of CFS patients

By better understanding daily activity levels and heart rate patterns of those who suffer from Chronic Fatigue Syndrome (CFS), scientists hope to discover more about this complex illness condition.

24 Jun 2016

New study reveals conversion of oral cannabidiol to THC by acidic fluids in the stomach

A new study demonstrating the conversion of oral cannabidiol (CBD) to the psychoactive component tetrahydrocannabinol (THC) in the presence of gastric fluids could explain why children given CBD to treat epilepsy had an unexpectedly high rate of adverse effects such as sleepiness and fatigue.

22 Jun 2016

Long-term opioid therapy may not be effective to manage pain in sickle cell disease patients

In a small study looking at pain assessments in adults with sickle cell disease, researchers at Johns Hopkins says overall, those treated long-term with opioids often fared worse in measures of pain, fatigue and curtailed daily activities than those not on long-term opioids.

21 Jun 2016

Mental fatigue can impair football performance

Professional footballers and their coaches often complain about the mental fatigue induced by the stress of frequent matches.

17 Jun 2016

Fatigue News and Research

Lifting lighter weights many times can be effective alternative way to gain muscle strength

Study identifies new blood markers to accurately diagnose Gulf War Illness

Moderate to vigorous physical activity linked to improved memory in breast cancer survivors

Relaxing acupressure improves fatigue levels in breast cancer survivors

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

FDA approves Absorb GT1 BVS to treat coronary artery disease

First-line nivolumab promising in advanced NSCLC

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients

Wolbachia bacterium can prevent mosquitoes from transmitting Zika virus

Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

Study highlights continuing problem of MSI in Gulf War veterans

Epclusa drug receives FDA approval for treating adult patients with chronic HCV

Why does appetite loss occur during illness? An interview with Prof. Conti and Prof. Francesconi

The scent dogs smell on diabetics’ breath could offer key to new tests

Scientists detect biological markers of chronic fatigue syndrome in gut bacteria

Stony Brook researcher receives grant to evaluate daily activity levels, heart rate patterns of CFS patients

New study reveals conversion of oral cannabidiol to THC by acidic fluids in the stomach

Long-term opioid therapy may not be effective to manage pain in sickle cell disease patients

Mental fatigue can impair football performance

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News